Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT02607943
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02607943
-
- Other papers using this trial's data
- A randomized trial to investigate the efficacy and safety of insulin glargine in hyperglycemic acute stroke patients receiving intensive care
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT02607943. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke
- Acronym
- ICAS
- Condition
- Acute Stroke
- Condition
- Hyperglycemia
- Intervention (Drug)
- Insulin Glargine
- Intervention (Drug)
- Regular Insulin
- Lead sponsor
- National Taiwan University Hospital
- Collaborator
- Chang Gung Memorial Hospital
- Collaborator
- Taipei Medical University Shuang Ho Hospital
Record details
- Record id
cardio:ct-nct02607943- Content hash
aea39e5e0e9c3b08adc6d6aaececd9b800f291e92b2cc033c1b20118d036e0d3